Year: 2017
Author: Shihai Gu, Chunyuan Hou
Communications in Computational Chemistry, Vol. 5 (2017), Iss. 3 : pp. 86–95
Abstract
Clone the Harvoni$^{\rm TM}$(Sofosbuvir/Ledipasvir) tablet manufactured by Gilead Sciences, Inc. and screen out the best formula of prescription, to make the pesticide effect of prepared tablet was equal to the original tablet. Methods: Based on the prescription of HarvoniTM manufactured by Gilead Sciences, Inc., the compatibility test of the excipient with the active ingredient was carried out. The stability of self-made samples and reference preparations were investigated, which includes high temperature, high humidity and light conditions. According to the above test, the most reasonable prescription process was chosen. Results: The determined prescription process contained sofosbuvir (400mg), ledipasvir (90mg), copovidone (97.5mg), croscarmellose sodium (50mg), microcrystalline cellulose (115mg), lactose monohydrate (230mg), magnesium stearate (7.5mg), gum arabic(10mg), opadry film coating powder, and purified water. Conclusion: The determined prescription process was stable and the pesticide effect of prepared tablet was equal to the original tablet, so the prescription design was reasonable.
You do not have full access to this article.
Already a Subscriber? Sign in as an individual or via your institution
Journal Article Details
Publisher Name: Global Science Press
Language: English
DOI: https://doi.org/10.4208/cicc.2017.v5.n3.4
Communications in Computational Chemistry, Vol. 5 (2017), Iss. 3 : pp. 86–95
Published online: 2017-01
AMS Subject Headings: Global Science Press
Copyright: COPYRIGHT: © Global Science Press
Pages: 10
Keywords: Harvoni$^{\rm TM}$ Prescription Technology Sofosbuvir.